Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...
Read Full NewsUltragenyx seeks FDA accelerated approval for UX111 gene therapy in Sanfilippo syndrome, citing neurologic benefit and the use of cerebral spinal fluid heparan sulfate data.
Here's some of what is coming soon to NeurologyLive® this week.
AGNOS trial showed that monthly treatment with ofatumumab lowered NfL and GFAP in patients with early RRMS, signaling reduced nerve damage and bolstering first-line treatment potential.
Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.
The FDA issued a CRL for gene therapy RGX-121 in Hunter syndrome, citing trial design and biomarker doubts; Regenxbio seeks a meeting with the agency and resubmission.
In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'
New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis
1.
FDA Expands Durvalumab Label to Operable Lung Cancer
2.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
3.
Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.
4.
Six breast texture patterns linked to higher risk of invasive cancer
5.
Cancer Patients Are Receiving More and More Stupid Immunotherapy.
1.
Tertiary Lymphoid Structures: Pivotal Players in Cancer Prognosis and Therapeutic Response
2.
Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies
3.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
4.
Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time
5.
From Birthmarks to Tumors: The Science Behind Infantile Hemangioma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge